The Journal of Organic Chemistry
Page 6 of 8
5-(Chloromethyl)-3-(p-tolyl)-4,5-dihydroisoxazole
(4b).1
129.9 , 126.6, 80.2 , 52.2 , 44.7 , 38.1 .HRMS (ESI) m/z calcd for
1
2
3
4
5
6
7
8
Compound 4b was prepared following the general procedure B.
The reaction of 1b (35.0 mg, 0.2 mmol) give 4b as white soild (45.0
mg. 97%); mp 76-77℃, Rf = 0.33 (petroleum ether/ethyl acetate
10:1). 1H NMR (500 MHz, CDCl3) δ 7.55 (d, J = 8.1 Hz, 2H), 7.21
(d, J = 7.9 Hz, 2H), 4.92 – 4.86 (m, 1H), 3.49 (dd, J = 17.0, 10.3
Hz, 1H), 3.40 (dd, J = 10.5, 4.1 Hz, 1H), 3.18 – 3.24 (m, 2H),2.38
(s, 3H).
C12H13ClNO3 [M+H]+ : 254.0578, found 254.0577.
5-(Chloromethyl)-3-(3-nitrophenyl)-4,5-dihydroisoxazole
(4j).
Compound 4j was prepared following the general procedure B. The
reaction of 1j (41.2 mg, 0.2 mmol) give 4j as white soild (37.2 mg,
78%); mp 84-85℃, Rf = 0.29 (petroleum ether/ethyl acetate 5:1);
1H NMR (500 MHz, CDCl3) δ 8.43 (t, J = 1.9 Hz, 1H), 8.26 (m,
1H), 8.11 – 8.00 (m, 1H), 7.61 (t, J = 8.0 Hz, 1H), 5.13 – 5.08 (m,
1H), 3.74 (dd, J = 11.5, 4.2 Hz, 1H), 3.65 (dd, J = 11.5, 6.8 Hz,
1H), 3.55 (dd, J = 17.0, 10.7 Hz, 1H), 3.40 (dd, J = 17.0, 6.7 Hz,
1H). 13C{1H} NMR (125 MHz, CDCl3) δ 154.5, 148.4, 132.2,
130.8, 129.8, 124.7, 121.5, 80.5, 44.8, 37.9. HRMS (ESI) m/z calcd
for C10H10ClN2O3 [M+H]+ : 241.0375, found 241.0373.
5-(Chloromethyl)-3-(4-methoxyphenyl)-4,5-dihydroisoxazole
(4c).1 Compound 4c was prepared following the general procedure
B. The reaction of 1c (38.2 mg, 0.2 mmol) give 4c as white soild
(36.9 mg. 83%); mp 72-74℃, Rf = 0.36 (petroleum ether/ethyl
acetate 5:1). 1H NMR (500 MHz, CDCl3) δ 7.61 – 7.59 (d, J = 8.8
Hz, 2H), 6.92 – 6.90 (d, J = 8.8 Hz, 2H), 4,96 – 4.91 (m, 1H), 3.83
(s, 1H), 3.69 (dd, J = 11.2, 4.4 Hz, 1H), 3.55 (dd, J = 11.2, 7.5 Hz,
1H), 3.36 (dd, J = 16.9, 10.5 Hz, 1H), 3.30 (dd, J = 16.9, 6.3 Hz,
1H).
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
3-(3,4-dimethoxyphenyl)-5-(Chloromethyl)-4,5-dihydroisoxazole
(4k). Compound 4k was prepared following the general procedure
B. The reaction of 1k (44.2 mg, 0.2 mmol) give 4k as white soild
(39.8 mg, 78%); mp 74-76 ℃ , Rf = 0.21 (petroleum ether/ethyl
3-(4-fluorophenyl)-5-(Chloromethyl)-4,5-dihydroisoxazole (4d).1
Compound 4d was prepared following the general procedure B.
The reaction of 1d (35.8 mg, 0.2 mmol) give 4d as white soild (37.0
mg. 87%); mp 58-59℃, Rf = 0.30 (petroleum ether/ethyl acetate
acetate 5:1); H NMR (500 MHz, CDCl3) δ 7.36 (d, J = 1.9 Hz,
1
1H), 7.04 (dd, J = 8.3, 2.0 Hz, 1H), 6.84 (d, J = 8.3 Hz, 1H), 4.99
– 4.91 (m, 1H), 3.90 (s, 6H), 3.69 (dd, J = 11.2, 4.3 Hz, 1H), 3.55
(dd, J = 11.2, 7.5 Hz, 1H), 3.47 (dd, J = 16.8, 10.4 Hz, 1H), 3.30
(dd, J = 16.8, 6.3 Hz, 1H). 13C{1H} NMR (125 MHz, CDCl3) δ
155.8, 151.0, 149.1, 121.7, 120.4, 110.5, 108.7, 79.6, 55.8 (d, J =
3.2 Hz), 44.8, 38.6, 29.6. HRMS (ESI) m/z calcd for C12H15ClNO3
[M+H]+ : 256.0735, found 256.0739.
1
10:1). H NMR (500 MHz, CDCl3) δ 7.69 – 7.66 (m, 1H), 7.07 –
7.14 (m, 1H), 4.96 – 5.01 (m, 1H), 3.71 (dd, J = 11.3, 4.2 Hz, 1H),
3.57 (dd, J = 11.3, 7.3 Hz, 1H), 3.47 (dd, J = 16.9, 10.5 Hz, 1H),
3.32 (dd, J = 16.9, 6.5 Hz, 1H).
3-(4-chlorophenyl)-5-(Chloromethyl)-4,5-dihydroisoxazole (4e).1
Compound 4e was prepared following the general procedure B.
The reaction of 1e (39.1 mg, 0.2 mmol) give 4e as white soild (45.0
mg. 97%); mp 85-86℃, Rf = 0.32 (petroleum ether/ethyl acetate
10:1). 1H NMR (500 MHz, CDCl3) δ 7.59 (d. J =7.1 Hz, 2H), 7.37
(d, J = 7.1 Hz, 2H), 4.97 – 5.02 (m, 1H), 3.70 (dd, J = 9.5, 3.6 Hz,
1H), 3.58 (dd, J = 9.5, 6.0 Hz, 1H), 3.46 (dd, J = 14.0, 8.8 Hz, 1H),
3.30 (dd, J = 14.0, 5.4 Hz, 1H).
5-(chloromethyl)-3-(o-tolyl)-4,5-dihydroisoxazole (4l). Compound
4l was prepared following the general procedure B. The reaction of
1l (35.0 mg, 0.2 mmol) give 4l as light yellow oil (25.4 mg, 61%);
Rf = 0.28 (petroleum ether/ethyl acetate 10:1); 1H NMR (500 MHz,
CDCl3) δ 7.35 (dd, J = 7.6, 1.1 Hz, 1H), 7.33 – 7.23 (m, 3H), 4.96
– 4.91 (m, 1H), 3.61 – 3.53 (m, 2H), 3.72 (dd, J = 11.3, 4.3 Hz,
1H), 3.39 (dd, J = 16.9, 6.2 Hz, 1H), 2.56 (s, 3H). 13C{1H} NMR
(125 MHz, CDCl3) δ 156.9, 138.1, 131.6, 129.6, 128.9, 128.1,
125.9, 78.7, 44.9, 41.1, 22.8. HRMS (ESI) m/z calcd for
C11H13ClNO [M+H]+ : 210.0680, found 210.0680.
3-(4-bromophenyl)-5-(Chloromethyl)-4,5-dihydroisoxazole (4f).1
Compound 4f was prepared following the general procedure B. The
reaction of 1f (48.0 mg, 0.2 mmol) give 4f as white soild (51.7 mg,
95%); mp 105-106 ℃ , Rf = 0.30 (petroleum ether/ethyl acetate
2-(5-(Chloromethyl)-4,5-dihydroisoxazol-3-yl)phenol
(4m).
Compound 4m was prepared following the general procedure B
with 0.4 mmol of Na2CO3 (42.4 mg). The reaction of 1m (35.4 mg,
0.2 mmol) give 4m as white soild (30.6 mg, 73%); mp 67-68℃, Rf
= 0.37 (petroleum ether/ethyl acetate 10:1);1H NMR (500 MHz,
CDCl3) δ 9.64 (s, 1H), 7.38 – 7.30 (m, 1H), 7.21 (dd, J = 7.8, 1.6
Hz, 1H), 7.04 (dd, J = 8.3, 1.0 Hz, 1H), 6.94 (m, 1H), 5.01 – 4.96
(m, 1H), 3.73 (dd, J = 11.4, 4.4 Hz, 1H), 3.65 – 3.53 (m, 2H), 3.45
(dd, J = 16.9, 6.5 Hz, 1H). 13C{1H} NMR (125 MHz, CDCl3) δ
158.1, 157.3, 132.0, 128.4, 119.6, 117.1, 113.5, 78.6, 44.5, 38.7.
HRMS (ESI) m/z calcd for C10H11ClNO2 [M+H]+ : 212.0472,
found 212.0474.
1
10:1); H NMR (500 MHz, CDCl3) δ 7.52 (s, 4H), 3.30 (dd, J =
16.9, 6.5 Hz, 1H), 5.02 – 4.96 (m, 1H), 3.70 (dd, J = 11.4, 4.3 Hz,
1H), 3.58 (dd, J = 11.3, 7.2 Hz, 1H), 3.46 (dd, J = 16.9, 10.5 Hz,
1H).
5-(Chloromethyl)-3-(4-nitrophenyl)-4,5-dihydroisoxazole (4g).18
Compound 4g was prepared following the general procedure B.
The reaction of 1g (41.2 mg, 0.2 mmol) give 4g as white soild (38.0
mg, 80%); mp 154-155℃, Rf = 0.38 (petroleum ether/ethyl acetate
1
3:1); H NMR (500 MHz, CDCl3) δ 8.32 – 8.20 (m, 2H), 7.89 –
7.79 (m, 2H), 5.12 – 5.07 (m, J = 10.9, 6.8, 4.1 Hz, 1H), 3.75 (dd,
J = 11.5, 4.1 Hz, 1H), 3.65 (dd, J = 11.5, 7.0 Hz, 1H), 3.53 (dd, J =
17.0, 10.7 Hz, 1H), 3.39 (dd, J = 17.0, 6.7 Hz, 1H).
5-(chloromethyl)-3-(naphthalen-2-yl)-4,5-dihydroisoxazole (4n).1
Compound 4n was prepared following the general procedure B.
The reaction of 1n (42.2 mg, 0.2 mmol) give 4n as white soild (34.9
mg, 71%); mp 78-79℃, Rf = 0.30 (petroleum ether/ethyl acetate
10:1); 1H NMR (500 MHz, CDCl3) δ 7.96 (dd, J = 8.7, 1.7 Hz, 1H),
7.91 (s, 1H), 7.88 – 7.81 (m, 3H), 7.57 – 7.48 (m, 2H), 5.07 – 5.00
(m, 1H), 3.75 (dd, J = 11.3, 4.4 Hz, 1H), 3.65 – 3.58 (m, 2H), 3.46
(dd, J = 16.8, 6.5 Hz, 1H).
5-(Chloromethyl)-3-(4-(trifluoromethyl)phenyl)-4,5-
dihydroisoxazole (4h).18 Compound 4h was prepared following the
general procedure B. The reaction of 1h (45.8 mg, 0.2 mmol) give
4h as white soild (50.3 mg, 95%); mp 79-80 ℃ , Rf = 0.36
(petroleum ether/ethyl acetate 10:1); 1H NMR (500 MHz, CDCl3)
δ 7.79 (d, J = 8.1 Hz, 2H), 7.67 (d, J = 8.3 Hz, 2H), 5.06 (m, 1H),
3.74 (dd, J = 11.4, 4.2 Hz, 1H), 3.62 (dd, J = 11.4, 7.2 Hz, 1H),
3.52 (dd, J = 17.0, 10.7 Hz, 1H), 3.37 (dd, J = 17.0, 6.6 Hz, 1H).
5-(chloromethyl)-3-(thiophen-2-yl)-4,5-dihydroisoxazole
(4o).1
Compound 4o was prepared following the general procedure B.
The reaction of 1o (33.4 mg, 0.2 mmol) give 4o as light yellow oil
(34.2 mg, 85%); Rf = 0.26 (petroleum ether/ethyl acetate 10:1);1H
NMR (500 MHz, CDCl3) δ 7.41 (dd, J = 5.1, 1.1 Hz, 1H), 7.23 (dd,
J = 3.6, 1.1 Hz, 1H), 7.07 (dd, J = 5.1, 3.7 Hz, 1H), 5.01 – 4.96 (m,
1H), 3.71 (dd, J = 11.3, 4.3 Hz, 1H), 3.60 – 3.49 (m, 2H), 3.35 (dd,
J = 16.8, 6.4 Hz, 1H).
3-(4-bromophenyl)-5-(chloromethyl)-4,4-dimethyl-4,5-
dihydroisoxazole (4p). Compound 4p was prepared following the
general procedure B. The reaction of 1p (53.6 mg, 0.2 mmol) give
methyl
4-(5-(Chloromethyl)-4,5-dihydroisoxazol-3-yl)benzoate
(4i). Compound 4i was prepared following the general procedure
B. The reaction of 1i (43.8 mg, 0.2 mmol) give 4i as white soild
(42.5 mg, 84%); mp 124-126℃, Rf = 0.26 (petroleum ether/ethyl
1
acetate 5:1); H NMR (500 MHz, CDCl3) δ 8.04 (d, J = 6.7 Hz,
2H), 7.71 (d, J = 8.6 Hz, 2H), 4.99 – 5.04 (m, 1H), 3.91 (s, 3H),
3.71 (dd, J = 11.3, 4.3 Hz, 1H), 3.60 (dd, J = 11.3, 7.1 Hz, 1H),
3.50 (dd, J = 16.9, 10.6 Hz, 1H), 3.34 (dd, J = 16.9, 6.6 Hz, 1H).
13C{1H} NMR (125 MHz, CDCl3) δ 166.3, 155.5 , 133.1 , 131.4 ,
ACS Paragon Plus Environment